Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Nov 25,2015
Novel Nanocarriers Open Door to Better Treatment for Brain Cancer
A Lawrence Berkeley National Laboratory researcher thinks she might have found a solution to transporting therapeutics across the blood-brain barrier to treat a deadly form of brain cancer. Ting Xu, Ph.D., a polymer scientist specializing in self-assembling bio/nano hybrid materials, has developed a new family of nanocarriers formed from the self-assembly of amphiphilic peptides and polymers.
More
Novel Nanocarriers Open Door to Better Treatment for Brain Cancer
Nov 23,2015
New Antibiotic Resistance Gene That Breaches 'Last Line of Defense'
    A new gene has been discovered that allows bacteria to become resistant to our last line of antibiotic defense. The gene, MCR-1, was found to be widespread in pigs and patients in south China, with some strains having epidemic potential.  MCR-1 was found to enable bacteria to become resistant to polymyxins; the colistin and polymyxinRead more
More
Nov 23,2015
Single Gene Found to Play Huge Role in Brain Development
    Researchers at the Institute of Molecular Biology (IMB) in Mainz, Germany say they have unraveled a complex regulatory mechanism that explains how a single gene can drive the formation of brain cells. Their study ("NeuroD1 reprograms chromatin and transcription factor landscapes to induce the neuronal program”), published in The EMBO Journal, is an important stepRead more
More
Single Gene Found to Play Huge Role in Brain Development
Nov 23,2015
RNA-Based Drugs Give More Control Over Gene Editing
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego SchoolRead more
More
Nov 23,2015
Nano Sensor Measures MicroRNAs Could Speed Up Cancer Detection
    The role of microRNAs in the detection of various types of cancer has become increasingly evident over the past several years. However, a major drawback of using these molecules as a diagnostic indicator of disease has been developing a method that is sensitive enough to detect minuscule amounts of the genetic material in a timeframeRead more
More
Nano Sensor Measures MicroRNAs Could Speed Up Cancer Detection
Nov 20,2015
Novel Therapeutics Show Promise for Treating Persistent Tuberculosis
    Researchers from the Florida campus of the Scripps Research Institute (TSRI) say they have discovered several first-in-class compounds that target inactive Mycobacterium tuberculosis bacteria that hide inside cell aggregates, latent and persistent, waiting to break out. The researchers described a technique in ACS Chemical Biology ("First-in-Class Inhibitors of Sulfur Metabolism with Bactericidal Activity against Non-ReplicatingRead more
More
Nov 20,2015
Researchers Discover Novel Cancer Immunotherapy Target
    Scientists from the Institut de recherches cliniques de Montreal (IRCM) led by André Veillette, M.D., have identified the mechanism of action for a new target for novel immune-oncology treatments. Their discovery ("DNAM-1 controls NK cell activation via an ITT-like motif”) is described in the Journal of Experimental Medicine.     The researchers study natural killer (NK) cells,Read more
More
Researchers Discover Novel Cancer Immunotherapy Target
Nov 20,2015
Small Molecule Drug Candidates
Modern drug development is no longer a "Shen Nong tastes herbs” model. First, it is ethically not allowed. Drugs that enter the clinic must not only have a certain basis for patient benefit, but also ensure safety. Second, if certain screening is not carried out, there are too many compounds to be tested clinically, whichRead more
More
Small Molecule Drug Candidates
Nov 19,2015
Human Brain Peeled Back to Its Transcriptional Core
The human brain has so many organizational layers that you might wonder whether there is, deep down, a core that we all share, however diverse our brains are in other respects. It turns out that there is a core, report scientists at the Allen Institute for Brain Science. This core, the scientists say, is transcriptionalRead more
More
Nov 19,2015
Scientists Turn Bacterial Molecules into Potential Drug Molecules
    Scientists have figured out how to turn bacterial molecules into potential drug molecules.   Scientists at Syracuse University say they have created molecules that mimic and dominate toxic ones secreted by bacteria. They believe that these molecules might be turned into potential drugs.     “Using toxic molecules to develop therapeutic agents, such as a vaccine, is notRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->